Ludovico Muzii

No ORCID on file · 109 papers in corpus · active 1992-2026

Study types

  • article 72
  • review 21
  • other 9
  • book-chapter 2
  • letter 2

Condition tags

  • mesh:D004715 54
  • endometriosis 48
  • endometrioma 29
  • infertility 25
  • chronic_pelvic_pain 13
  • dysmenorrhea 13
  • mesh:D017699 12
  • adenomyosis 10
  • dyspareunia 7
  • mesh:D004412 7
review 2026
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2025.105429

Endometriomas can be managed through various approaches, including careful observation, medical suppressive therapy, or surgical intervention. Malignancy is rarely a concern in women of reproductive age, making pain relief and the managemen…

review 2026
Human reproduction open ·doi:10.1093/hropen/hoaf064

STUDY QUESTION: Are endometriotic lesions affecting bilateral organs or anatomical structures distributed symmetrically on both sides of the body? SUMMARY ANSWER: The left-sided preponderance of pelvic endometriotic lesions, and the right-…

article 2026
·doi:10.1016/j.ijgc.2025.103566
article 2026
·doi:10.6084/m9.figshare.32049406

To evaluate the clinical efficacy and safety of a once-daily oral fixed-dose combination of relugolix 40 mg, estradiol 1 mg, and norethisterone acetate 0.5 mg in women with symptomatic adenomyosis coexisting with uterine fibroids. This case…

article 2026
·doi:10.6084/m9.figshare.32049406.v1

To evaluate the clinical efficacy and safety of a once-daily oral fixed-dose combination of relugolix 40 mg, estradiol 1 mg, and norethisterone acetate 0.5 mg in women with symptomatic adenomyosis coexisting with uterine fibroids. This case…

other 2026
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2026.2659439

OBJECTIVE: To evaluate the clinical efficacy and safety of a once-daily oral fixed-dose combination of relugolix 40 mg, estradiol 1 mg, and norethisterone acetate 0.5 mg in women with symptomatic adenomyosis coexisting with uterine fibroids…

review 2025
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/aogs.15145

Abstract Introduction Dienogest is a synthetic fourth‐generation progestin that has been approved for the medical treatment of endometriosis, and its efficacy on pain symptoms and quality of life is well established even in the long term. N…

preprint 2025
·doi:10.20944/preprints202501.1441.v1

Background/Objectives: Endometriosis affects up to 10% of women of reproductive age and about 47% of adolescents with pelvic pain. Symptoms include dysmenorrhea, dyspareunia, and chronic pelvic pain (CPP). Adolescents often present atypical…

other 2025
Journal of clinical medicine ·doi:10.3390/jcm14041392

Background/Objectives: Endometriosis affects up to 10% of women of reproductive age and about 47% of adolescents with pelvic pain. Symptoms include dysmenorrhea, dyspareunia, and chronic pelvic pain (CPP). Adolescents often present atypical…

preprint 2025
·doi:10.22541/au.174219896.60883322/v1

Objective: Endometriosis may negatively affect the ovarian reserve, and also endometriosis surgery may cause further damage to the ovarian reserve. There is lack of definite data for the effect of endometriomas and treatments on the ovarian…

article 2025
Frontiers in endocrinology ·doi:10.3389/fendo.2025.1631108

Background The effects of current treatment options for endometrioma on ovarian reserve remain controversial. Recent advancements in surgical techniques may challenge the previously established evidence regarding the detrimental effects of …

meta-analysis 2025
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-024-03323-2

The objective of this study is to evaluate if medical treatment before assisted reproductive technology (ART) improves the results in infertile patients with adenomyosis. A literature search was performed with EMBASE, PubMed, and Cochrane. …

article 2025
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2025.113940
article 2025
·doi:10.1093/humrep/deaf097.636

Abstract Study question Does pain catastrophizing mediate the relationship between pain interference and depression in women with endometriosis-related chronic pelvic pain (CPP)? Summary answer In women with endometriosis and CPP, catastrop…

article 2024
·doi:10.1016/j.rbmo.2024.104518
other 2024
Archives of gynecology and obstetrics ·doi:10.1007/s00404-024-07631-x

PURPOSE: This cross-sectional study aims to assess the interplay between the vaginal microbiota and endometriosis. METHODS: 123 consecutive Italian fertile women, aged between 20 and 40 years old, were enrolled during a routine gynecologic…

other 2024
Archives of gynecology and obstetrics ·doi:10.1007/s00404-024-07741-6

PURPOSE: There is several albeit not univocal evidence suggesting that ovarian reserve is not related to the chance of natural pregnancy, provided that the remnant follicular pool is sufficient to ensure regular menstrual cycles. Neverthele…

article 2024
The journal of pain ·doi:10.1016/j.jpain.2024.104640
article 2024
·doi:10.1093/hropen/hoae007
review 2024
Healthcare (Basel, Switzerland) ·doi:10.3390/healthcare12232435

Objectives: The purpose of this study was to evaluate the impact of endometriosis on various outcomes of in vitro fertilization (IVF), including live birth rates, clinical pregnancy rates, fertilization rates, and implantation rates, throug…

review 2024
Journal of clinical medicine ·doi:10.3390/jcm13113302

Background/Objectives: Adenomyosis is a benign condition characterized by the presence of endometrial tissue within the myometrium. Despite surgery being a valuable approach, medical options are considered as the first-line approach and hav…

review 2023
Biomedicines ·doi:10.3390/biomedicines12010001

Chronic pelvic pain (CPP) is generally defined as non-cyclic pain perceived in the pelvic area that has persisted from three to six months or longer and is unrelated to pregnancy. The etiology of CPP is complex, multifactorial, with heterog…

article 2023
International journal of environmental research and public health ·doi:10.3390/ijerph20064686

Background: Endometriosis is a chronic, estrogen-dependent, inflammatory disease, whose pivotal symptoms are dysmenorrhea, dyspareunia, and chronic pelvic pain (CPP). Besides the usual medical treatments, recent evidence suggests there are …

review 2023
Journal of clinical medicine ·doi:10.3390/jcm12051858

Management options for ovarian endometriomas include expectant management, medical treatment, surgical treatment, in vitro fertilization (IVF), or a combination of the above. The choice of management depends on many clinical parameters that…

other 2023
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2023.03.017

The evaluation of endometriosis in an adolescent girl is a challenging topic. The initial stage of the disease and the limited diagnostic instrument appropriate for the youth age and for its typical features can reduce the ability of the gy…